---
title: "Ocean Biomedical, Inc. (OCEA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/OCEA.US.md"
symbol: "OCEA.US"
name: "Ocean Biomedical, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T07:13:18.233Z"
locales:
  - [en](https://longbridge.com/en/quote/OCEA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OCEA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OCEA.US.md)
---

# Ocean Biomedical, Inc. (OCEA.US)

## Company Overview

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company’s infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.oceanbiomedical.com](https://www.oceanbiomedical.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 0.00 | 61 | - | - | - |
| PB | 0.00 | 447 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/OCEA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/OCEA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/OCEA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/OCEA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**